Skip Navigation Links

Bayer AG | Company Information from ICIS

 

Bayer is an agrochemicals, polymers and healthcare company with its activities in four subgroups of largely independent operations:  Bayer HealthCare, Bayer CropScience, Bayer MaterialScience and Bayer Business Services.

 

Bayer HealthCare focuses on consumer health care businesses to capitalise on growth opportunities, particularly in over-the-counter medicines, self-testing systems and animal health products. Bayer CropScience is a supplier of crop protection, seeds, biotechnology and non-agricultural pest control. Bayer MaterialScience is a major plastics producer and Bayer Business Services is the group's IT-based competence centre providing business, administrative and scientific services.

 

Bayer's business strategy will continue to focus on “fast-growing innovation-driven” health care, nutrition and high-tech materials businesses. It will strategically align itself into attractive markets and concentrate on its core competencies.

 

Bayer aims to invest more intensively in growth areas and innovative technologies in order to achieve a leadership role. It will also go ahead with cost-containment and efficiency-improvement efforts in order to further increase the company's value over the long term.

 

With headquarters in Leverkusen, Germany, Bayer has sales of around Euro33bn (2008) and around 108,600 employees.

 

ICIS Chemical Business magazine has unveiled the ICIS Top 100 Chemical Companies, with rankings based on 2008 sales.

 

A PDF of the ICIS Top 100 Chemical Companies is available for download on ICIS connect.

 

See the article and analysis of the ICIS Top 100 on ICIS news.

 

Key Personnel

 

Chairman: Werner Wenning (retires 30/04/10)

Chief executive officer: Marijn Dekkers (starts 01/11/10)
Member (strategy and HR): Richard Pott
Member (finance): Klaus Kuhn (retires 30/04/10)

Chief financial officer: Werner Baumann (starts 01/01/10)
Member (innovation, technology and environment): Wolfgang Plischke

 

(Updated September 2009)

 

Contacts

 

Bayer AG
Werk Leverkusen
51368 Leverkusen
Germany

Tel: +49 0 214 301
Fax: +49 0 214 308 

www.bayer.com

Bayer AG Company Structure

Bayer AG is an agrochemicals, polymers and healthcare group. The Bayer’s roots date back to 1863 where Friedrich Bayer and Johann Friedrich Weskott opened a modest dye works by the name Friedr. Bayer & Co. in Wuppertal-Barmen. The company's headquarters were moved in 1912 to Leverkusen, Germany, on the banks of the Rhine, where it has remained to this day.
More about Bayer AG Structure

Bayer AG Strategy & Financial Highlights

Bayer's business strategy will continue to focus on “fast-growing innovation-driven” health care, nutrition and high-tech materials businesses. It will strategically align itself into what Bayer calls “attractive markets” and concentrate on its core competencies. It aims to invest more intensively in growth areas and innovative technologies in order to achieve a leadership role. It will also go ahead with cost-containment and efficiency-improvement efforts in order to further increase the company's value over the long term. (Edited from: “Chairman's letter” and Annual Report). ICIS also provides you with key financial data listed in table form. More about Bayer AG Strategy & Financial Highlights

News:

Get news on Bayer AG plus the latest chemical news, information, data, market movements and analysis in one place with ICIS news

Search:

Find details on other chemical companies and suppliers with ICIS search

Newsletters:

ICIS offers a range of FREE e-newsletters to ensure that you don't miss out on the latest development and key market intelligence in your industry. If you want the latest news sent to your inbox, sign up for ICIS e-newsletters today.

Plants and projects:

Find out more about current and planned chemical plants and projects by subscribing to our comprehensive database

 
Free trial to ICIS
Barbara Ortner - Chemicals Confidential Blog
Take a look at the off-beat side of reporting on the global chemicals industry with Barbara Ortner who reports from key industry events and behind the scenes at training sessions across three continents by clicking on to ICIS Chemicals Confidential.

Insight

INSIGHT: Valuation key behind Reliance bid for LyondellBasell
"A $12bn offer would also make room for another company to outbid Reliance." more

VIDEO – ICIS news Americas Lunchtime Bulletin 23 November 2009

More...

We welcome your feedback. Please feel free to send us your comments on any aspect of this site. Click here to make your comments.